Reference: 974794 · Switzerland · Online, technology & IT
Strategic investment in a digital-health company
Investment opportunityReference: 974794COMPANY PROFILE
Acquisition opportunity at a glance
The company, a spin-off from the University of Zurich, develops medically certified software under Swissmedic MDD requirements for the digital diagnosis of mental illnesses. It standardizes, structures and accelerates diagnostic processes. The solution systematically captures psychological symptoms, visualizes them in a clear symptom map and generates clinically validated diagnostic suggestions.
It thereby helps professionals reach well-founded diagnostic decisions more quickly and initiate targeted treatment at an early stage. Earlier detection, better diagnoses and low-threshold access to suitable solutions generally reduce costs and improve the well-being of affected individuals. With more than six years of research background, the company has been on the market since 2019.
It offers Europe’s first and only clinically validated instrument for psychological diagnostics.
Key highlights
- Revenue: €550,000
- Result (metric unspecified): Not stated
- Employees: 15
CONTROLLED INFORMATION RELEASE
Confidential company information
Enter your contact details, receive the NDA by email and explicitly confirm the NDA and 5% buyer commission in a two-step process.